1. Academic Validation
  2. Discovery and SAR Study of Boronic Acid-Based Selective PDE3B Inhibitors from a Novel DNA-Encoded Library

Discovery and SAR Study of Boronic Acid-Based Selective PDE3B Inhibitors from a Novel DNA-Encoded Library

  • J Med Chem. 2024 Feb 8;67(3):2049-2065. doi: 10.1021/acs.jmedchem.3c01562.
Ann M Rowley 1 Gang Yao 2 Logan Andrews 3 Aaron Bedermann 1 Ross Biddulph 4 Ryan Bingham 4 Jennifer J Brady 3 Rachel Buxton 4 Ted Cecconie 1 Rona Cooper 1 Adam Csakai 2 Enoch N Gao 1 Melissa C Grenier-Davies 2 Meghan Lawler 2 Yiqian Lian 1 Justyna Macina 4 Colin Macphee 4 Lisa Marcaurelle 2 John Martin 1 Patricia McCormick 1 Rekha Pindoria 4 Martin Rauch 1 Warren Rocque 1 Yingnian Shen 1 Lisa M Shewchuk 1 Michael Squire 1 Will Stebbeds 4 Westley Tear 2 Xin Wang 3 Paris Ward 1 Shouhua Xiao 3
Affiliations

Affiliations

  • 1 GSK, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States.
  • 2 GSK, Encoded Library Technologies, NCE Molecular Discovery, 200 Cambridge Park Drive, Cambridge, Massachusetts 02140, United States.
  • 3 23andMe Inc, Therapeutics, 349 Oyster Point Boulevard, South San Francisco, California 94080, United States.
  • 4 GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, Hertfordshire, U.K.
Abstract

Human genetic evidence shows that PDE3B is associated with metabolic and dyslipidemia phenotypes. A number of PDE3 family selective inhibitors have been approved by the FDA for various indications; however, given the undesirable proarrhythmic effects in the heart, selectivity for PDE3B inhibition over closely related family members (such as PDE3A; 48% identity) is a critical consideration for development of PDE3B therapeutics. Selectivity for PDE3B over PDE3A may be achieved in a variety of ways, including properties intrinsic to the compound or tissue-selective targeting. The high (>95%) active site homology between PDE3A and B represents a massive obstacle for obtaining selectivity at the active site; however, utilization of libraries with high molecular diversity in high throughput screens may uncover selective chemical matter. Herein, we employed a DNA-encoded library screen to identify PDE3B-selective inhibitors and identified potent and selective boronic acid compounds bound at the active site.

Figures
Products